SEPTInvestingStart Free

SOPH SCHEDULE 13D/A: Insider sale planned

Filed with the SEC on · accession 0001178913-26-005168

SOPH filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Nov 12, 2026. aMoon Edge Limited Partnership, an affiliate of reporting persons including Dr. The stock moved +5.3% by the first close after the filing.

Summary of the filing

aMoon Edge Limited Partnership, an affiliate of reporting persons including Dr. Yair C. Schindel, sold 192,541 ordinary shares of SOPHiA GENETICS in a private block sale at $7.70 per share for gross proceeds of approximately $1.48 million. Following the sale, aMoon Growth Fund holds 5,318,023 shares, representing approximately 6.2% of the company's outstanding shares.

For details, click here →

Key details

Gross proceeds from sale of 192,541 ordinary shares$1.5M
Sale price per ordinary share$8
Ordinary shares held by aMoon Growth after sale$5.3M
IssuerSOPHiA GENETICS SA
Reporting person / shareholder holding 5,318,023 shares (6.2%)aMoon Growth Fund Limited Partnership
Reporting person / seller of 192,541 sharesaMoon Edge Limited Partnership
General partner of amoon growthaMoon Growth Fund G.P. Limited Partnership
General partner of amoon growth g.p.aMoon General Partner Ltd.
General partner of amoon edgeaMoon Edge GP Ltd.
Reporting personHilliyon Holdings Ltd.
Reporting personBerko Capital Ltd.
Reporting person / sole shareholder of amoon general partner ltd.Yair Chaim Schindel
Director of berko capital ltd. / reporting personTomer Berkovitz

How SOPH stock reacted

Close before

$7.46

Nov 11, 2026

First close after

+5.29%

$7.86

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for SOPH, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SOPH?

Click here

Frequently asked questions

What did SOPH file with the SEC on Nov 12, 2026?

SOPH filed a SCHEDULE 13D/A (Insider sale planned). aMoon Edge Limited Partnership, an affiliate of reporting persons including Dr. Yair C. Schindel, sold 192,541 ordinary shares of SOPHiA GENETICS in a private block sale at $7.70 per share for gross proceeds of approximately $1.48 million. Following the sale, aMoon Growth Fund holds 5,318,023 shares, representing approximately 6.2% of the company's outstanding shares.

How do I read a SCHEDULE 13D/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).

How did SOPH stock react to this filing?

SOPH closed at $7.46 before the filing and $7.86 on Nov 12, 2026 (+5.29%).

Other SOPH SEC filings

Get alerts when SOPH files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
SOPH overviewSOPH analysisSOPH newsLatest SEC filings